1. Home
  2. NEO vs WVE Comparison

NEO vs WVE Comparison

Compare NEO & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEO
  • WVE
  • Stock Information
  • Founded
  • NEO 2001
  • WVE 2012
  • Country
  • NEO United States
  • WVE Singapore
  • Employees
  • NEO N/A
  • WVE N/A
  • Industry
  • NEO Precision Instruments
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • NEO Health Care
  • WVE Health Care
  • Exchange
  • NEO Nasdaq
  • WVE Nasdaq
  • Market Cap
  • NEO 965.2M
  • WVE 984.9M
  • IPO Year
  • NEO 1999
  • WVE 2015
  • Fundamental
  • Price
  • NEO $7.17
  • WVE $6.25
  • Analyst Decision
  • NEO Buy
  • WVE Strong Buy
  • Analyst Count
  • NEO 9
  • WVE 11
  • Target Price
  • NEO $13.31
  • WVE $20.91
  • AVG Volume (30 Days)
  • NEO 1.6M
  • WVE 1.3M
  • Earning Date
  • NEO 04-29-2025
  • WVE 05-08-2025
  • Dividend Yield
  • NEO N/A
  • WVE N/A
  • EPS Growth
  • NEO N/A
  • WVE N/A
  • EPS
  • NEO N/A
  • WVE N/A
  • Revenue
  • NEO $672,361,000.00
  • WVE $104,939,000.00
  • Revenue This Year
  • NEO $13.95
  • WVE N/A
  • Revenue Next Year
  • NEO $11.16
  • WVE N/A
  • P/E Ratio
  • NEO N/A
  • WVE N/A
  • Revenue Growth
  • NEO 10.10
  • WVE N/A
  • 52 Week Low
  • NEO $6.08
  • WVE $4.25
  • 52 Week High
  • NEO $19.12
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • NEO 37.02
  • WVE 44.91
  • Support Level
  • NEO $7.28
  • WVE $5.98
  • Resistance Level
  • NEO $7.63
  • WVE $6.30
  • Average True Range (ATR)
  • NEO 0.36
  • WVE 0.31
  • MACD
  • NEO -0.00
  • WVE 0.03
  • Stochastic Oscillator
  • NEO 9.26
  • WVE 47.37

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: